Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Blood-activating and stasis-dissolving decoction (Huoxue Huayu Decoction) is a Traditional Chinese Medicine (TCM) formulation developed and extensively studied by researchers at the Beijing University of Chinese Medicine for the treatment of intracerebral hemorrhage (ICH). The decoction is a multi-herbal combination typically containing ingredients such as *Salvia miltiorrhiza* (Danshen), *Paeoniae Radix Rubra* (Chishao), *Chuanxiong Rhizoma* (Chuanxiong), *Carthamus tinctorius* (Honghua), and *Prunus persica* (Taoren). Its therapeutic mechanism is centered on the TCM principle of 'Huoxue Huayu,' which translates to promoting blood circulation and resolving blood stasis. Biologically, the decoction has been shown to facilitate the absorption of intracranial hematomas, reduce perihematomal brain edema, and protect the blood-brain barrier by inhibiting matrix metalloproteinase-9 (MMP-9) and downregulating pro-inflammatory cytokines like TNF-α and IL-6. Clinical trials conducted by the Beijing University of Chinese Medicine suggest that the formula improves neurological recovery and reduces secondary brain injury in patients following a hemorrhagic stroke.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on blood-activating and stasis-dissolving decoction.